Product review on the IMD serogroup B vaccine Bexsero®

Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates. When administered alone, Bexsero® showed a safety profile similar to othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Deghmane, Ala-Eddine, Taha, Muhamed-Kheir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Meningococcal – Product Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986181/
https://www.ncbi.nlm.nih.gov/pubmed/35192786
http://dx.doi.org/10.1080/21645515.2021.2020043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986181/
https://www.ncbi.nlm.nih.gov/pubmed/35192786
http://dx.doi.org/10.1080/21645515.2021.2020043

Ejemplares similares